Lykos Therapeutics clinical trials
A subsidiary of Resilient Pharmaceuticals
The registry lists 28 studies whose lead sponsor is Lykos Therapeutics. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 10, 2025.
Registry sponsor names on this page
- Lykos Therapeutics28 studies
Something wrong with this grouping? Tell us on the Resilient Pharmaceuticals page.
Studies
Recruiting first, then most recently updated. Showing 28 of 28. All Resilient Pharmaceuticals studies →
- MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic FunctionNot yet recruitingNCT03606538Phase 1
Sponsor listed in the registry: Lykos Therapeutics
- Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD (Canada)CompletedNCT03485287Phase 2
Sponsor listed in the registry: Lykos Therapeutics
- Randomized, Double-blind, Placebo-Controlled Pilot Study of MDMA-assisted Therapy for PTSDCompletedNCT01689740Phase 2
Sponsor listed in the registry: Lykos Therapeutics
- A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)CompletedNCT03537014Phase 3
Sponsor listed in the registry: Lykos Therapeutics
- A Multi-Site Open-Label Extension Study of MDMA-Assisted Psychotherapy for PTSDCompletedNCT04714359Phase 3
Sponsor listed in the registry: Lykos Therapeutics
- A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2)CompletedNCT04077437Phase 3
Sponsor listed in the registry: Lykos Therapeutics
- MDMA-Assisted Psychotherapy in People With Posttraumatic Stress DisorderCompletedNCT00090064Phase 2
Sponsor listed in the registry: Lykos Therapeutics
- Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic AdultsCompletedNCT02008396Phase 2
Sponsor listed in the registry: Lykos Therapeutics
- Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSDCompletedNCT01793610Phase 2
Sponsor listed in the registry: Lykos Therapeutics
- MDMA-Assisted Psychotherapy for Anxiety Associated With a Life-Threatening IllnessCompletedNCT02427568Phase 2
Sponsor listed in the registry: Lykos Therapeutics
- Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSDCompletedNCT03282123Phase 2
Sponsor listed in the registry: Lykos Therapeutics
- Randomized, Double-blind, Controlled of MDMA-assisted Psychotherapy in 12 Subjects With PTSDTerminatedNCT01958593Phase 2
Sponsor listed in the registry: Lykos Therapeutics
- Randomized Placebo-controlled Study of MDMA-assisted Therapy in People With PTSD - IsraelTerminatedNCT00402298Phase 2
Sponsor listed in the registry: Lykos Therapeutics
- Study Comparing Three Doses of MDMA Along With Therapy in Veterans With Posttraumatic Stress DisorderCompletedNCT01211405Phase 2
Sponsor listed in the registry: Lykos Therapeutics
- MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic PTSDCompletedNCT02876172Phase 1/2
Sponsor listed in the registry: Lykos Therapeutics
- Evaluation of MDMA on Startle ResponseCompletedNCT03181763Phase 1
Sponsor listed in the registry: Lykos Therapeutics
- Correlates of Anxiety Associated With a Life-threatening IllnessCompletedNCT02954562
Sponsor listed in the registry: Lykos Therapeutics
- A Multi-site Expanded Access Program for MDMA-assisted Psychotherapy for Patients With Treatment-resistant PTSDNo longer availableNCT04438512
Sponsor listed in the registry: Lykos Therapeutics
- Exploring Mechanisms of Action in MDMA-assisted Psychotherapy for PTSDCompletedNCT02102802
Sponsor listed in the registry: Lykos Therapeutics
- Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSDWithdrawnNCT04968938Phase 2
Sponsor listed in the registry: Lykos Therapeutics
- A Multi-Site Study of MDMA-Assisted Psychotherapy for Eating DisordersWithdrawnNCT04454684Phase 2
Sponsor listed in the registry: Lykos Therapeutics
- Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers (MT-2)WithdrawnNCT04073433Phase 1
Sponsor listed in the registry: Lykos Therapeutics
- Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy VolunteersCompletedNCT01404754Phase 1
Sponsor listed in the registry: Lykos Therapeutics
- Study of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in VeteransWithdrawnNCT05173831Phase 2
Sponsor listed in the registry: Lykos Therapeutics
- Long-Term Safety and Effectiveness of MDMA-Assisted Therapy for PTSDCompletedNCT05066282
Sponsor listed in the registry: Lykos Therapeutics
- Food Effects on Bioavailability of MDMA in Healthy VolunteersCompletedNCT05147402Phase 1
Sponsor listed in the registry: Lykos Therapeutics
- Study of 3,4-Methylenedioxymethamphetamine-assisted Psychotherapy in People With Posttraumatic Stress DisorderCompletedNCT00353938Phase 2
Sponsor listed in the registry: Lykos Therapeutics
- Additional MDMA-assisted Therapy for People Who Relapsed After MDMA-assisted Therapy TrialCompletedNCT01458327Phase 2
Sponsor listed in the registry: Lykos Therapeutics